(1 - 12 von 12
)
GSK Announces CHMP Positive Opinion for Labelling Update to Relvar...
www.finanznachrichten.de
Jonathan Sweeting, SVP and Global Head of Respiratory Franchise GSK, said: "There are many asthma patients in Europe who, despite being adequately controlled on a twice-daily ICS/LABA, are still ...
EU approves label update to Relvar Ellipta in patients with ...
www.pharmabiz.com
— Jonathan Sweeting, SVP and head of global respiratory franchise GSK, said: "Patients with asthma can continue to experience symptoms despite ... › News...
Innoviva, GSK: EU Approves Label Update To Relvar Ellipta ...
www.finanznachrichten.de
Jonathan Sweeting, SVP and Head of Global Respiratory Franchise GSK, said: 'Patients with asthma can continue to experience symptoms despite being adequately controlled and these symptoms can ...
GSK's Nucala improves control of severe asthma - PharmaTimeswww.pharmatimes.com › news › g...
www.pharmatimes.com
... patients who are not well controlled by omalizumab,” noted Jonathan Sweeting, SVP and head, Global Respiratory Franchise at GSK.
GSK announces labelling update to Relvar Ellipta - Investis
otp.investis.com
— Jonathan Sweeting, SVP and Head of Global Respiratory Franchise GSK, said: Patients with asthma can continue to experience symptoms despite ... › rns_new
Kiadis Pharma N. V. - Kiadis Pharma strengthens core team with three...
cws.huginonline.com
Mr. Dirk De Naeyer has been appointed Head of Supply Chain, Mr. Jonathan Sweeting has been appointed Head of Commercial Europe and ...
Kiadis Pharma strengthens core team with three senior
www.globenewswire.com
— Arthur Lahr, CEO of Kiadis Pharma, commented: "I am delighted to welcome Dirk De Naeyer, Jonathan Sweeting and Marcel Zwaal to Kiadis. Building ... › ...
Investor Relations - GSK Announces CHMP Positive Opinion for...
investor.inva.com
· Jonathan Sweeting , SVP and Global Head of Respiratory Franchise GSK, said: "There are many asthma patients in Europe who, despite being ...
Label update for Relvar Ellipta approved by EC
www.oindpnews.com
— GSK Senior VP and Head of Global Respiratory Franchise Jonathan Sweeting commented, “Patients with asthma can continue to experience ... › labe...
Międzynarodowy koncern farmaceutyczny zatrudnia w Poznaniu
biznes.newseria.pl
Międzynarodowy koncern farmaceutyczny zatrudnia w Poznaniu 700 specjalistów IT. To oni wspierają 100 tys. pracowników na całym świecie w pracy nad nowymi...
The PM Society Advertising Awards PMLiVE
www.pmlive.com
This year's awards ceremony took place on January 30, at the Grosvenor House Hotel in London, and despite the financial turmoil of 2008, 350 entries from more...
KIADIS Kiadis Pharma strengthens core team with three senior...
www.webdisclosure.com
KIADIS Kiadis Pharma strengthens core team with three senior appointments, Informations réglementées, informations financières, directive transparence
sortiert nach Relevanz / Datum